Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Brisbane, CA
SEC filing record 1 source field available
Fiscal year end
30 November
Nurix Therapeutics, Inc. has filed 545 SEC EDGAR filings since 15 May 2012

SEC filing history

Showing 201-225 of 545 matching filings.

Per page
25
Current page
9
4

FORM 4

Filing date
26 Aug 2024
Reporting date
26 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Aug 2024
Reporting date
26 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39398

144 filing

Filing date
26 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39398

144 filing

Filing date
26 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Aug 2024
Reporting date
01 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Aug 2024
Reporting date
01 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39398

144 filing

Filing date
01 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39398

144 filing

Filing date
01 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jul 2024
Reporting date
30 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jul 2024
Reporting date
30 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jul 2024
Reporting date
30 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Jul 2024
Reporting date
17 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-280117

424B5

Filing date
11 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39398

144 filing

Filing date
01 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Jun 2024
Reporting date
20 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39398

144 filing

Filing date
20 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Jun 2024
Reporting date
13 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Jun 2024
Reporting date
12 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-280117

S-3ASR

Filing date
11 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91591

SC 13G/A filing

Filing date
07 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .